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BACKGROUND: Mesothelioma mortality has increased more than ten-fold over the past 40 years in Great Britain, with 41700 male
deaths recorded in the British mesothelioma register in 2006. Annual mesothelioma deaths now account for 41% of all cancer
deaths. A Poisson regression model based on a previous work by Hodgson et al has been fitted, which has allowed informed
statistical inferences about model parameters and predictions of future mesothelioma mortality to be made.
METHODS: In the Poisson regression model, the mesothelioma risk of an individual depends on the average collective asbestos dose for
the individual in a given year and an age-specific exposure potential. The model has been fitted to the data within a Bayesian
framework using the Metropolis–Hastings algorithm, a Markov Chain Monte Carlo technique, providing credible intervals for model
parameters as well as prediction intervals for the number of future cases of mortality.
RESULTS: Males were most likely to have been exposed to asbestos between the ages of 30 and 49 years, with the peak year of
asbestos exposure estimated to be 1963. The estimated number of background cases was 1.08 cases per million population.
CONCLUSION: Mortality among males is predicted to peak at approximately 2040 deaths in the year 2016, with a rapid decline
thereafter. Approximately 91000 deaths are predicted to occur from 1968 to 2050 with around 61000 of these occurring from
2007 onwards.
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Mesothelioma is a cancer that mainly affects the pleura (the
membrane that covers the lungs and lines the internal chest wall)
and the peritoneum (the membrane that forms the lining of
the abdominal cavity). Of all deaths, 85% have been among
men and the majority of these were caused by occupational
exposure to asbestos fibres (Rake et al, 2009). The disease has a
long latency period; symptoms usually emerge between 15 and 60
years after exposure to asbestos, after which mesothelioma is
rapidly fatal. The majority of deaths occur among those 460 years
of age, with few deaths occurring among those o50 years.
Although the majority of cases of mesothelioma are caused by
exposure to asbestos, much of which occurred in occupational
settings, particularly among men, a small number of cases
occur spontaneously among those with no history of exposure.
Annual mesothelioma deaths have increased more than ten-fold
over the past 40 years and now account for 41% of all cancer
deaths.
Predictions of mesothelioma mortality have been made in
several countries. Clements et al (2007) modelled mesothelioma
mortality in Australia using both an age–birth cohort model and a
model based on that introduced by Hodgson et al (2005). Banaei
et al (2000) predicted mortality in France using a method based on
a risk function that links mortality with past exposure to asbestos.
Segura et al (2003) used an age–period–cohort model to predict
mortality in the Netherlands. Hodgson et al (2005) developed
a model based on the estimated collective population exposure
to asbestos and a specific form for the relationship between
mesothelioma risk and time since first exposure at the population
level. The model was fitted to mesothelioma mortality for Great
Britain up to 2001 and projections of mortality were made by
applying fitted mesothelioma rates to future population projec-
tions. Confidence intervals for the parameters and prediction
intervals for future estimated annual deaths could not be made
because of limitations in the optimisation approach adopted. This
paper presents the results of a Bayesian statistical analysis to refit
a modified version of this model using updated mortality data
up to 2006 and a Markov Chain Monte Carlo (MCMC) method
of computation. The Bayesian approach allowed credible and
prediction intervals to be calculated; thus, informed statistical
inferences about model parameters and predictions of future
mortality, in particular the scale and timing of the peak in deaths,
could be made.
MATERIALS AND METHODS
The model
The British Mesothelioma Register contains all deaths in Great
Britain since 1968 in which mesothelioma was mentioned on the
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ydeath certificate. It provides the basis for a consistent data series of
mesothelioma mortality over nearly four decades. In both males
and females, 99% of all these deaths are among those between the
ages of 20 and 89 years. The data used in the analyses carried out
in this report are based on deaths of males aged 20–89 years,
between 1968 and 2006. The model developed by Hodgson et al
(2005) is based on that developed by the Health Effects Institute
(1991). In brief, the Health Effects Institute (1991) model, in which
an individual’s mesothelioma risk is assumed to be proportional
to the increase in cumulative exposure multiplied by a power
of time since exposure lagged by 10 years, was applied at the
population level; this was achieved by assuming that the average
asbestos exposure for males in Great Britain in each year can be
summarised by a single estimate and that their exposure in any
given year also depends on their age. Parameters to model change
in completeness of mesothelioma diagnosis over time and the
clearance half-life of asbestos fibres in the lungs were also
included. Allowance for a background rate of mesotheliomas not
caused by asbestos exposure was not originally included by
Hodgson et al (2005); however, background cases may account
for a higher proportion of deaths in certain years and among the
most recent birth cohorts, and we have included a term to allow
for such cases in the modified version of the model that can be
represented as follows:
lA;T ¼
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where lA,T is the number of deaths at age A in year T, WA is
the overall age-specific exposure potential at age A, DT is the
overall population exposure in year T, DxT is the proportion
of mesothelioma deaths in year T that are recorded, L is the lag
period in years between exposure and disease occurrence, H is the
half-life in years for asbestos clearance from the lungs, k is the
power of time representing the increase of risk with increase of
time since exposure, PA,T is the person-years at risk for age A in
year T, M is the total observed mesothelioma deaths from 1968 to
2006, I is an indicator variable where I¼0i floL–1 and I¼1
otherwise, l indexes years lagged from the risk year and BA,T is the
number of background cases for age A at year T.
Modelling technique
The model was originally fitted by Hodgson et al (2005) using
a manual iterative approach to minimising the model deviance.
In this case, the deviance can be expressed as
D ¼ 2
X
A;T
YA;Tlog
YA;T
^ lA;T
 !
  YA;T   ^ lA;T
  
"#
; ð2Þ
where YA,T are the observations and lA,T are the fitted values.
However, confidence intervals for both the parameter estimates
and predictions of mortality could only be obtained using an
informal numerical approach rather than analytically. We used a
more refined statistical analysis using the Metropolis–Hastings
algorithm (Metropolis et al, 1953; Hastings, 1970), an MCMC
method. This method allows not only model parameters to be
estimated, but also Bayesian credibility intervals to be easily
obtained using formal statistical methods, which is the main
advantage of adopting a Bayesian approach. Because of the
number of parameters and the complexity of the model, it would
have been difficult to adopt a frequentist approach to obtain
parameter estimates and confidence intervals.
Model parameters
(i) The age-specific exposure potential, WA, allowed the expo-
sure of males in a given year to vary by age. Nine parameters
were assigned to WA, representing the exposure weighting for
the age groups 0–4, 5–15, 16–19, 20–29, 30–39, 40–49,
50–59, 60–64 and 65þ, with the age group 20–29 years
chosen as the baseline category.
(ii) The overall population exposure, DT,r e p r e s e n t st h ea v e r a g e
‘effective carcinogenic dose’ in the breathing zone of men aged
20–89 years and is included as a unit-free parameter vector in
t h em o d e l .T h es h a p eo ft h ee x p o s u r ec u r v ea n dt h ec h a n g ei n
exposure levels over time is the main interest in the inclusion
of DT. DT was defined by growth and decline rates for years in
multiples of 10 before and after the maximum exposure year,
called Peakyear (at which the gradient of the exposure curve is
zero). The growth rates for intermediate years were determined
by linear interpolation. The set of growth rates at Peakyear  65,
Peakyear  55, Peakyear  45, Peakyear  35, Peakyear  25,
Peakyear  15, Peakyear  5, Peakyear þ5a n dPeakyear þ15
was included as a multivariate parameter in the model.
Parameters defining the exposure distribution in the most
recent years could not be estimated because of the long latency
period of mesothelioma; instead, assumptions about the level
of exposure from the year 2000 based on the HSE Regulatory
Impact Assessment (HSE, 2002) were used as in Hodgson et al
(2005). From the year 2000 onwards, it was assumed that the
total asbestos exposure to the population would be approxi-
mately 4% of the peak value in 2000, 2% in 2010 and 0.75% in
2050. Between the last year for which the growth rate was
estimated and 2000, the value of the exposure was determined
by linear interpolation.
(iii) The diagnostic trend DxT was defined by a parameter a,
representing the annual percentage decrease in the number of
missed cases, working backwards in time from 1997, in which
diagnosis was assumed to be essentially complete (98%).
(iv) The background rate is represented by the number of cases
per million in the male population. The age distribution of
the background cases in each year is assumed to be (A L)
k.
The proportion of background cases at age A in each year is
therefore assumed to be A   L ðÞ
k=
P
A
A   L ðÞ
k.
Population projections
To obtain mesothelioma mortality projections from 2007 to 2050,
population projections of the number of males aged between
20 and 89 at every year between 2007 and 2050 were obtained from
the Office for National Statistics.
The model
From a Bayesian perspective, the parameters of a statistical model
are considered random quantities. Bayesian inference can usually
be summarised by random draws from the posterior distributions
of the model parameters. Let Lik(Y|y) be the likelihood function
of the data Y, y be the vector of model parameters and f(y)
be the prior distribution of the parameters, which represents the
prior information we have on y. The posterior distribution p(y)
of y is
py ðÞ / Lik Yjy ðÞ fy ðÞ : ð3Þ
Assuming that the observations follow a Poisson distribution, the
likelihood function is
Lik Yjy ðÞ ¼
Y
A;T
e ^ lA;T^ l
YA;T
A;T
YA;T!
 !
ð4Þ
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each observation over all ages and years of death. We assumed that
all possible parameter values within a chosen interval were equally
likely by using uniform prior distributions. The intervals were
chosen by considering the maximum plausible ranges, taking
into account the results of Hodgson et al (2005).
Statistical inference
Unfortunately, because of the complexity of the likelihood, the
posterior distribution is unavailable in closed form. Numerical
techniques, particularly MCMC, are thus required to evaluate the
posterior distribution. Thus, MCMC techniques require simulation
to generate random samples from a complex posterior distribu-
tion. We generated 35000 sets of random draws from the joint
posterior distribution of the model parameters after a burn-in
of 20000 iterations to minimise the effect of initial values on
posterior inference. After the burn-in period, the empirical
distributions should eventually approximate the true shapes of
the posterior distributions closely. Point estimates and credible
intervals are then calculated from this distribution.
Proposal distributions
Apart from the proposal distribution for Peakyear, each distri-
bution was chosen to be normal with s.d. such that the accep-
tance probability ranged between 20 and 45%. It should be
noted that the proposal distributions do not have an effect on
the posterior parameter estimates, but only on the conver-
gence, mixing and autocorrelation of the chains generated by
the Metropolis–Hastings algorithm. The Metropolis–Hastings
algorithm was implemented in Matlab (The MathsWorks,
Inc., Natick, MA, USA; 2008).
Prior distributions
Non-informative prior distributions for each parameter were
chosen by considering plausible ranges, taking into account the
results in Hodgson et al (2005). In the previous analysis, k has been
estimated at between 2 and 3. It was unlikely that the risk
decreased with time since exposure, and hence the prior for k was
chosen to be U(0,10). Each of the W parameters represents age-
specific exposure potential and can only take positive values. It was
considered unlikely that the risk in any of the age groups was
10 times greater than that of males aged 20–29 years (the baseline
age group), and hence the priors for W were chosen to be U(0,10).
Each of the D parameters represents the growth rates of population
exposure levels. As the overall population exposure can only take
positive values the decline rate must not exceed 100%, and hence
the lower bound for D must be  100. Taking into account the data
on asbestos imports as well as the levels of asbestos use in Great
Britain, the peak year of exposure was assumed to be between 1950
and 2000, and hence the prior distribution of Peakyear was chosen
to be uniformly distributed on integer values between 1950 and
2000. By definition, the background rate can only take positive
values. Hodgson et al (2005) suggest that a background rate of
1 to 2% of total mesothelioma deaths, equating to approxi-
mately 25–50 male deaths annually, is widely assumed. A uniform
U(0,20) prior was chosen for a (cases per million). As a result of
problems encountered when attempting to estimate H, various
prior distributions for H were considered. Table 1 shows the prior
distributions that were used.
RESULTS
The parameter estimates are shown in Table 2. The parameter
L was fixed at 10, as in Hodgson et al (2005).
Exponent of time
The posterior median of the exponent of time, k, was 2.42.
Half-life
Increasing the clearance half-life parameter H was found to
improve model fit in preliminary analysis; however, conver-
gence in the posterior distribution for H was unattained after
several thousand iterations of the MCMC algorithm, suggesting
that there is no finite optimal value of H. In light of this, H was
fixed at 1000000 years in the final model, corresponding to
virtually no clearance of asbestos from the lungs. However, there
was high negative correlation between H and k; fixing k to
larger values led to lower simulated samples of H. It was thus
difficult to obtain a value of H that is close to the true value. The
large half-life value of 1000000 years was selected as it resulted in
a better fit than a lower value; however, it should be interpreted
with caution.
Table 1 Prior distributions for model parameters
Parameter Prior
H Various
kU (0, 10)
Wk8kU (0, 10)
Dk8kU ( 100, 200)
a U( 0.07, 0.09)
Peakyear U(1950, 2000)
Rate U(0, 20)
Table 2 Parameter estimates from fitting Poisson regression model
Parameter
Metropolis–Hastings
Posterior median
(90% CI)
Hodgson
et al (2005)
Estimate
Power of time since exposure, k 2.42 (2.28, 2.56) 2.6
Background rate, Rate (per million) 1.08 (0.71, 1.51) —
Maximum exposure year, Peakyear 1963 1967
Clearance half-life, H (years) 1000000 (fixed) 1000 (fixed)
Diagnostic trend, a (%) — 5
Change in exposure index (percentage per year) in peak year±X years
 65 0 (fixed) —
 55 1000 (fixed) —
 45 100000 (fixed) 29
 35  91.3 ( 98.2,  50.1) 6
 25 104.6 (44.8, 135.5) 11
 15  25.5 ( 34.9,  8.28) 9
 5 36.6 (23.2, 47.8) 5
0 (Peak year) 0 (by definition) 0 (by definition)
5  7.5 ( 14.1,  1.4)  14
15  18.6 ( 27.5,  8.8)  39
Relative exposure potential for age group (years)
0–4 0.0019 (0.0001, 0.0074) 0.00
5–15 0.0023 (0.0002, 0.0091) 0.03
16–19 0.25 (0.048, 0.393) 0.21
20–29 1.00 (baseline) 1.00
30–39 1.79 (1.51, 2.03) 1.24
40–49 1.59 (1.25, 1.94) 1.11
50–59 0.13 (0.01, 0.41) 0.00
60–64 0.56 (0.06, 1.54) 0.00
65+ 0.42 (0.03, 1.56) 0.00
Projection of mesothelioma mortality in Britain
E Tan et al
432
British Journal of Cancer (2010) 103(3), 430–436 & 2010 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yDiagnostic trend
The inclusion of the diagnostic trend component in the model did
not seem to improve the fit of the model. Although the best fitting
model was one in which the diagnostic trend component was
excluded, this does not necessarily imply that the proportion of
missed cases remains unchanged over time; changes may have
been encapsulated in the population exposure profile or the
background case component of the model.
Age-specific exposure potential
The estimates of the age-specific exposure potential parameters
suggested that this was highest among males aged 30 to 49 years,
with males aged o15 years and 450 years least likely to be exposed.
Convergence of the exposure time profile parameters could not be
achieved when all of these were included as estimated parameters.
Exposure profile
Along with the peak exposure year (1963), sharp local peaks in the
exposure profile were also present at Peakyear  35 and Peakyear
 15. Attempts were made to smooth the exposure profile before
the peak year by changing the assumptions of the population
exposure before Peakyear  45. However, several attempts resulted
in the rate of change in exposure levels at Peakyear  45 increasing
and failing to converge, as well as the rate at Peakyear  35
eventually taking up negative values. In light of this, the rates
of change in exposure levels at Peakyear  65, Peakyear  55
and Peakyear  45 were fixed at 0, 1000 and 1000000, respectively.
The estimated exposure curve in the final model indicated a high
level of exposure around Peakyear  35, soon followed by a sharp
decrease in exposure. A rapid increase in population exposure
followed from the 1940s to the mid-1960s, reaching a maximum in
1963 and decreasing thereafter.
Background rate
The background rate was estimated at 1.08 cases per million,
corresponding to approximately 23 cases in 2006 among males
aged 20 to 89 years.
Figure 1A–D shows plots of observed and fitted deaths by year
of birth, age of death and year of death for males aged between
20 and 89 years.
Projections
The peak year of mesothelioma mortality among males aged
between 20 and 89 years was projected to be 2016 (90% CI:
2015–2017). Although only very few deaths have occurred in males
o20 years or 489 years, this estimate has been rescaled to give the
total number of deaths among males of all ages. Predicted ratios,
projections and credible intervals for mesothelioma mortality in all
males are given in Table 3. The estimate of the peak number of
deaths in all males is 2038 (90% prediction interval 1929–2156) in
the year 2016 (90% CI: 2015–2016). A rapid decline in cases is
expected after the peak year. Approximately 91000 deaths are
predicted to occur from 1968 to 2050 with around 61000 of these
occurring from 2007 onwards. Figure 2 shows a plot of fitted and
observed deaths by year of death, along with a 90% prediction
interval for all male deaths.
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Figure 1 Metropolis–Hastings algorithm. (A) Observed and fitted deaths by year of birth. (B) Observed and fitted deaths by age. (C) Derived exposure
index. (D) Observed and fitted deaths for 1955–1985 birth cohorts.
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It has been shown that for many animal tumours, cancer incidence
rises approximately as some power of age or time since first
exposure to a carcinogen (Doll, 1971). Peto et al (1995) fitted a
model of this type to mesothelioma mortality data for North
American insulation workers and showed that incorporating a lag
of 10 years from asbestos exposure to disease occurrence provided
a better fit than assuming no lag period (Peto and Selikoff, 1982).
A lag of 10 years has subsequently been assumed by several
researchers (Hodgson et al, 2005) and has also been assumed in
this paper. Although there is a significant body of work that
supports a lag time of 10 years, a fixed lag does represent a strong
assumption. Therefore, a local sensitivity analysis of the lag time
was carried out to test the sensitivity of model results to this
assumption. Lag times between 0 and 15 years were considered.
Results showed that both the peak year and the peak number of
deaths were sensitive to the assumed lag. In particular, a lag of
0 resulted in a peak year further into the future, whereas a lag of
15 years moved the peak closer to present time. However, the
deviances calculated under these lags indicated a much poorer fit
to the data than under a lag of 10 years. The peak year and peak
number of deaths were not sensitive to small variations in about
a lag of 10 years.
Model adequacy
The deviance residuals may be used to measure the fit of the
Poisson model and are defined as
rD
A;T ¼ sign YA;T   ^ lA;T
  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2 YA;Tlog
YA;T
^ lA;T
  YA;T   ^ lA;T
  
"# v u u t ð5Þ
where r
D
A,T is the contribution to the deviance of the observation at
age A and year T and
sign x ðÞ ¼
 1if
0if
1if
xo0
x ¼ 0
x40
8
<
:
The distribution of the deviance residuals is approximately
normal. For a good fit, approximately 95% of the deviance
residuals should lie in the range [ 2, 2]. Out of the 126 deviance
residuals resulting from fitting the model, 121 (96%) lie in
the range [ 2, 2] when using the posterior medians of the
Metropolis–Hastings algorithm, suggesting a satisfactory fit.
DISCUSSION
In this analysis we found that a modified version of the model
developed by Hodgson et al (2005) provided a good statistical fit to
mesothelioma data from 1968 to 2006, suggesting that it provides a
sound basis for shorter-term projections of future levels of
mortality. Updated projections are broadly in agreement with
those based on earlier analyses.
The use of an improved optimisation approach based on MCMC
and Bayesian techniques provided increased confidence than in
previous analyses that the best fitting model was obtained, as well
as allowed a more thorough assessment of model adequacy and
model parameters to be made. It has also allowed the construction
of prediction intervals for the future mortality to be made.
Fitting the model revealed that the profile of estimated
population asbestos exposure over time had several local maxima,
whereas in previous analyses the profile increased monotonically
before the peak year and decreased monotonically thereafter. The
estimate of the global peak year of exposure was 1963 with local
peaks around 1930 and 1950, after which exposure rapidly
decreased. These peaks coincided with specific events that took
place in Great Britain that were likely to have had an effect on the
use of asbestos, which may explain the observed pattern to some
extent, although it seems unlikely that actual changes in
population exposure would have been as extreme. The first peak
coincides with the Great Depression as well as the establishment of
Asbestos Industry Regulations in 1931, which were introduced in
Great Britain to regulate the use of asbestos in the asbestos
industry, although this sharp peak may have been exaggerated by
the assumptions on exposure growth rates in earlier years. Even
when these assumptions were relaxed, the pattern of convergence
in the parameter estimates representing the exposure growth rates
in earlier years still indicated a peak around 1930. This peak,
however, only contributes to a small proportion of mesothelioma
deaths. When World War II took place between 1939 and 1945,
shipbuilding in naval yards increased as the industry saw a large
increase in demand. Use of asbestos in naval yards was likely to
have increased during that period. After the war, when demand
fell, shipbuilding activity decreased and thus the use of asbestos in
naval yards was likely to have decreased. The second local peak of
asbestos exposure coincides with this post-war reduction in
shipyard activity. These features of the population exposure
curve persist when refitting the model to observations of morta-
lity to 2001 (the basis for earlier analyses). This suggests that
Table 3 Projections of all male mesothelioma deaths
Year
Male 20–89 years
Projection (90% prediction interval)
2009 1910 (1827, 1993)
2010 1941 (1855, 2026)
2011 1968 (1870, 2059)
2012 1993 (1897, 2084)
2013 2012 (1913, 2106)
2014 2027 (1926, 2129)
2015 2035 (1929, 2141)
2016 2038 (1928, 2156)
2017 2037 (1928, 2147)
2018 2031 (1912, 2152)
2019 2017 (1903, 2141)
2020 1997 (1871, 2132)
2030 1462 (1314, 1626)
2040 708 (588, 851)
2050 396 (326, 487)
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Figure 2 Observed deaths with fitted 50th percentile curve and 90%
prediction interval.
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Hodgson et al (2005) are because of the improved model-fitting
approach rather than because of refinements to the model and
additional observations of mortality. As mesothelioma is usually
only diagnosed several decades after exposure to asbestos, and as
the peak year of mortality has yet to be reached, there is greater
uncertainty in the estimated exposure profile from mid-1960s
onwards.
In our model, the last year for which the population exposure
was estimated was 1978. The extent of the population exposure
beyond this point has limited effect on the predicted mesothelioma
deaths within the range of years for which observations of
mortality are available (up to 2006), and thus on the model fit.
Furthermore, predictions of the scale and timing of the peak
number of mesothelioma deaths are not highly dependent on
exposure after the late 1970s. However, the shape of the exposure
curve after 1978 is required to use the model to make longer-term
predictions. Some limited investigation of different exposure
curves suggested that a levelling off of the exposure in the late
1970s provides a marginally better fit than a continuing very steep
decline in exposure. However, such considerations cannot be used
as grounds for preferring one exposure curve over another.
Decisions regarding the shape of the exposure profile in this region
must draw on other sources of evidence about the extent of
population exposure more recently.
For our projections we used the same assumptions about
exposure beyond the year 2000 as in Hodgson et al (2005), and
additionally assumed a linear decline in exposure between 1978
and 2000. However, the prediction intervals of our projections
incorporate only the uncertainty in the fitted model parameters,
and not the unquantifiable but potentially considerable degree of
additional uncertainty arising from the particular chosen shape of
the exposure curve beyond 1978. For example, if the population
exposure levelled off in 1978 and then continued indefinitely at this
level rather than continuing to decline, as we have assumed, the
model predicts a much slower decline in mortality after the peak
year, and consequently much larger estimates of the total mortality
to year 2050 that exceed those based on our upper prediction
interval.
Although this analysis confirmed that the current model
provides a good fit to the observations of mesothelioma mortality
to date, and provides a reasonable basis for projections in the short
term, it is much less clear whether it provides a good basis for
longer-term projections, even if we could be more confident about
the exposure curve beyond 1978. Male mortality to date is still
dominated by the effect of substantial past occupational exposures,
and in these circumstances this model, in which mesothelioma risk
depends on a power of time since first exposure, seems to fit the
data well.
The estimated number of background cases was 1.08 cases per
million population, equivalent to 23 cases in 2006 among males
aged 20–89 years. This is in good agreement with the value of 1
to 2% of total cases as suggested by McDonald and McDonald
(1996), who carried out backward extrapolation of mesothelioma
mortality trends from epidemiological studies from various
countries; a figure of 1.15% (95% confidence interval 0.90–1.45)
has been suggested by Teta et al (2008) for males, based on US
mesothelioma patterns between 1973 and 2002. Although the
proportion of background cases in recent years among males
has been small compared with the relatively large number of
asbestos-related cases, the background cases will represent a larger
proportion of all cases in future years when the number of
asbestos-related cases will decline.
Hodgson et al (2005) included a diagnostic trend parameter in
their models, which was estimated at 5% in their non-clearance
model. The results of our analyses suggested little statistical
evidence for a diagnostic trend and no apparent improvement to
the fit of the model. Although the best fitting model was one in
which the diagnostic trend component was excluded, this does not
necessarily imply that the proportion of missed cases has remain
unchanged over time; changes in the proportion of missed cases
over time may have been encapsulated in the population exposure
profile or the background case component of the model.
The peak number of mesothelioma deaths among males aged
20–89 years reported in Hodgson et al (2005) was approximately
1846 deaths between 2011 and 2015 based on data up to 2001,
which is lower than the peak of 1990 (90% prediction interval
1886–2100) deaths among males ages 20–89 years in the year
2016 predicted in this study. However, more than half of the
difference in the peak number of deaths is because of the use of
updated projections of the future British population.
Different estimates of peak mesothelioma mortality have been
predicted in other countries; in Australia, the peak is expected at
approximately 700 cases per year in 2010 (Leigh and Driscoll,
2003). In France, the peak of approximately 2200 cases per year is
expected some time after 2020 (Ilg et al, 1998), whereas in the
Netherlands (Segura et al, 2003), up to 900 cases per year of pleural
mesothelioma are expected around the year 2028. These projec-
tions, among others that have been made for mesothelioma
mortality in Europe, indicate that although the number of deaths
has been rapidly increasing in recent years, mortality may not
reach a peak for several years. Although the pattern of projected
future mesothelioma mortality in Britain is broadly consistent with
these predictions for other industrialised countries, the scale of
mesothelioma mortality varies between countries and rates in
Britain are among the highest worldwide (Rake et al, 2009). This
is a reflection of large-scale importation and use of asbestos
particularly in building products. The assumptions that we have
made about future exposures are uncertain and the contri-
bution they will make to the cumulative total burden of
mesothelioma in the long run will ultimately depend on the
effectiveness of current controls to prevent inadvertent exposures
because of maintenance activities in buildings that still contain
asbestos products.
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